DRREDDY — Dr. Reddy's Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹1.02tn
- IN₹1.01tn
- IN₹337.00bn
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
Preview: Dr Reddy's opens Q2 earnings for Indian big pharma; investors brace for muted quarter
Brief: Dr Reddy's Receives Dcgi Approval For Zytorvi In Advanced Esophageal Squamous Cell Carcinoma
Brief: Dr Reddy's Got A Form 483 With Three Observations From US FDA
Factbox: Global healthcare companies invest billions to boost US presence
Brief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
India's Dr Reddy's rises as Nomura flags near-term biologics milestones
Dr. Reddy's rises on India distribution deal for Takeda's dengue vaccine
Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine (updated)
India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
Brief: Dr Reddy's Enters Exclusive Distribution Agreement With Takeda For Qdenga In India
Brief: Dr Reddy's Says USFDA Completes Records Assessment At Mexico API Facility
Brief: Dr Reddy's Says FDA Issued Form 483 With 4 Observations After Inspection Of Hyderabad Formulations Facility
Brief: Dr Reddy's Says USFDA Inspection At API Facility In UK Classified 'Voluntary Action Indicated' And Officially Closed
India Stocks: Indian shares subdued as higher crude prices weigh